Abstract

Objective: The present study focused on binding mode of the N3 inhibitor and Ganomestenol with receptor SARS-CoV-2 Mpro protease. Methods: The structure of ligands N3 inhibitor and Ganomestenol were designed and 3-D coordinates were prepared using ACD/ChemSketch 8.0 freeware. Autodock4 software was used to study the orientation of the inhibitor or ligand in the active site of biological receptor SARS-CoV-2 Mpro (PDB ID: 6LU7). The Lamarckian genetic algorithm was applied to both ligand and protein for energy minimization using default parameters. The results were analyzed by Ligplot and Pymol software. Results: The compound Ganomestenol designed in in-silico for molecular docking with SARS-CoV-2 protease (Mpro). The in-silico results showed significant binding energy (−6.93 kcal/mol) by comparing with N3 inhibitor (−3.51 kcal/mol). Conclusion: The affinity of Ganomestenol is highly significant compared to N3 inhibitor and also showed efficacy of ligand toward protease under in-silico condition.

Highlights

  • The affinity of Ganomestenol is highly significant compared to N3 inhibitor and showed efficacy of ligand toward protease under in-silico condition

  • The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the viral pneumonia which affects the respiratory infection in human and becomes an epidemic

  • Severe illness can be caused by the Middle East respiratory syndrome (MERS) and human coronavirus (HCoV) and SARS has the highest mortality [2]

Read more

Summary

Introduction

The affinity of Ganomestenol is highly significant compared to N3 inhibitor and showed efficacy of ligand toward protease under in-silico condition. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the viral pneumonia which affects the respiratory infection in human and becomes an epidemic. The virus consists of two clusters of proteins, namely, (i) the non-structural RNAdependent RNA polymerase (RRP) that is significant in the replication of the virus, and protease (Mpro) of SARS-CoV-2: Mpro protease enzyme plays a central role in mediating viral replication and transcription and (ii) Spike proteins mediate for fusion and passes into the host, nucleocapsid, matrix, and envelope proteins [3]. Targeting this protease (Mpro) halts the viral replication.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call